Hjem › Lungekreft › Illinois › Rockford
Kliniske studier for Lungekreft i Rockford, IL
5 studier for Lungekreft søker deltakere på steder i og rundt Rockford (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruttererFase 3
- OSF Saint Anthony Medical Center, Rockford
- UW Health Carbone Cancer Center Rockford, Rockford
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- OSF Saint Anthony Medical Center, Rockford
- Mercyhealth Cancer Institute - Rockford, Rockford
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RekruttererFase 3
- UW Health Carbone Cancer Center Rockford, Rockford
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RekruttererFase 3
- UW Health Carbone Cancer Center Rockford, Rockford
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruttererFase 2
- OSF Saint Anthony Medical Center, Rockford
Lungekreft-studier i andre byer
- Houston, TX78 studier
- Boston, MA62 studier
- New York City, NY60 studier
- Los Angeles, CA45 studier
- Washington, DC41 studier
- Arlington, VA41 studier
- Chicago, IL41 studier
- Nashville, TN40 studier
- Baltimore, MD40 studier
- St. Louis, MO39 studier
- Columbus, OH37 studier
- Philadelphia, PA36 studier
Andre studier i Rockford
- Brystkreft5 studier
- Ikke-småcellet lungekreft4 studier
- Kronisk nyresykdom3 studier
- Nyrekreft (nyrecellekarcinom)3 studier
- Kolorektal kreft3 studier
- Tykktarmskreft3 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.